Electromed 過去の業績
過去 基準チェック /66
Electromedは、平均年間33.8%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間13.6% 14.5%収益成長率で 成長しています。 Electromedの自己資本利益率は20.6%であり、純利益率は14.1%です。
主要情報
33.84%
収益成長率
34.24%
EPS成長率
| Medical Equipment 業界の成長 | 8.90% |
| 収益成長率 | 14.54% |
| 株主資本利益率 | 20.55% |
| ネット・マージン | 14.08% |
| 前回の決算情報 | 31 Mar 2026 |
最近の業績更新
Recent updates
ナラティブの更新 • Apr 18
ELMD: Refined Discount Rate And P/E Assumptions Will Drive Future Upside
Analysts raised their price target on Electromed by $2, reflecting updated assumptions about the discount rate, profit margin, revenue growth, and future P/E that support a slightly higher valuation framework. Analyst Commentary Bullish Takeaways Bullish analysts see the higher price target as consistent with refreshed assumptions on discount rate and future P/E that leave room for upside if execution stays on track.ナラティブの更新 • Apr 04
ELMD: Refreshed Discount Rate And P/E Assumptions Will Support Future Upside
Analysts have raised their price target on Electromed by $2, citing updated assumptions about discount rates, revenue growth, profit margins and future P/E that support a slightly higher fair value estimate. Analyst Commentary Bullish Takeaways Bullish analysts see the higher price target as consistent with refreshed assumptions on discount rates and future P/E, which together suggest more support for the current valuation than before.
ナラティブの更新 • Mar 21
ELMD: Share Repurchases And Margin Execution Will Support Future Upside
Analysts have raised their price target on Electromed by $2 to reflect updated assumptions around revenue growth, profit margin and long-term P/E expectations. Analyst Commentary Recent research points to a more cautious tone around Electromed, even alongside the higher price target.ナラティブの更新 • Mar 06
ELMD: Share Repurchases And Higher Margin Outlook Will Drive Future Upside
Analysts have increased their price target on Electromed by $2 to $36, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as key factors behind the change. Analyst Commentary While the new US$36 price target reflects updated valuation work, some bearish analysts are still flagging risk factors that they believe limit upside for Electromed at current levels.ナラティブの更新 • Feb 20
ELMD: Share Repurchases Will Support Future Upside In Undervalued Shares
Analysts have nudged their price target on Electromed up by $1 to $37, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E after the latest Street research. Analyst Commentary Recent Street research has focused on how Electromed's fundamentals line up with the revised fair value assumptions and the updated $37 target.ナラティブの更新 • Feb 06
ELMD: Completed Share Buyback Will Support Future Upside In Undervalued Shares
Analysts have adjusted their price target on Electromed to reflect a fair value of $36.00, citing only minor tweaks to assumptions around the discount rate, revenue growth, profit margin and future P/E. Their overall valuation view remains largely unchanged.ナラティブの更新 • Jan 21
ELMD: Share Buyback And Higher Margin Outlook Will Support Future Upside
Analysts have kept their price target for Electromed steady at US$34.00, reflecting updated views on slightly higher projected revenue growth and profit margins, along with a marginally adjusted discount rate and future P/E assumption. What's in the News Completed the repurchase of 40,848 shares, representing 0.49% of the company, for US$1 million under the share buyback announced on September 9, 2025 (Key Developments).ナラティブの更新 • Jan 07
ELMD: Higher Margin Outlook And Share Buyback Will Support Upside Potential
Analysts have raised their fair value estimate for Electromed from US$29 to US$34, citing updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change. What's in the News Between September 9, 2025 and September 30, 2025, Electromed repurchased 40,848 shares for US$1 million, representing 0.49% of shares.ナラティブの更新 • Dec 15
ELMD: Share Repurchase Program Will Support Future Upside In Undervalued Shares
Analysts have nudged their price target for Electromed slightly higher to approximately $36.00 per share, citing modest improvements in discount rate assumptions and forward valuation metrics while largely reaffirming their prior outlook. What's in the News Completed a share repurchase tranche totaling 40,848 shares, or about 0.49 percent of outstanding shares, for approximately $1 million under the buyback program announced September 9, 2025 (company filing) Valuation Changes Fair Value Estimate reaffirmed at approximately $36.00 per share, reflecting no material change in intrinsic value assumptions.ナラティブの更新 • Nov 30
ELMD: Share Repurchase Plan And Expanding Outlook Will Lift Share Price
Analysts have raised their price target for Electromed from $35.25 to $36.00. They cite an improved outlook for future revenue growth, despite a slightly higher discount rate and marginally lower profit margin projections.ナラティブの更新 • Nov 16
ELMD: Double-Digit Revenue Gains And Buybacks Will Drive Shares Higher
Electromed's analyst fair value target increased slightly from $35.00 to $35.25, as analysts cite consistent double-digit revenue growth forecasts and improving operational efficiency in recent reports. Analyst Commentary Bullish Takeaways Bullish analysts highlight Electromed's consistent double-digit revenue growth forecasts and note that ongoing top-line expansion is expected in the coming years.
新しいナラティブ • Feb 21
The Triple Down On Bronchiectasis Campaign Will Expand SmartVest Clearway's Market Reach
Diversifying beyond homecare and investing in sales efforts may drive revenue growth and improve earnings through expanded market channels and effective sales execution.収支内訳
収支内訳
Electromed の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 26 | 72 | 10 | 42 | 1 |
| 31 Dec 25 | 69 | 9 | 41 | 1 |
| 30 Sep 25 | 66 | 8 | 40 | 1 |
| 30 Jun 25 | 64 | 8 | 39 | 1 |
| 31 Mar 25 | 61 | 7 | 38 | 1 |
| 31 Dec 24 | 60 | 7 | 36 | 1 |
| 30 Sep 24 | 57 | 6 | 35 | 1 |
| 30 Jun 24 | 55 | 5 | 34 | 1 |
| 31 Mar 24 | 53 | 4 | 34 | 1 |
| 31 Dec 23 | 52 | 4 | 34 | 1 |
| 30 Sep 23 | 50 | 3 | 33 | 1 |
| 30 Jun 23 | 48 | 3 | 32 | 1 |
| 31 Mar 23 | 46 | 3 | 30 | 1 |
| 31 Dec 22 | 44 | 2 | 29 | 1 |
| 30 Sep 22 | 42 | 2 | 28 | 1 |
| 30 Jun 22 | 42 | 2 | 27 | 1 |
| 31 Mar 22 | 40 | 2 | 26 | 1 |
| 31 Dec 21 | 39 | 2 | 25 | 1 |
| 30 Sep 21 | 38 | 2 | 24 | 2 |
| 30 Jun 21 | 36 | 2 | 22 | 2 |
| 31 Mar 21 | 33 | 3 | 21 | 2 |
| 31 Dec 20 | 33 | 4 | 21 | 2 |
| 30 Sep 20 | 32 | 4 | 20 | 1 |
| 30 Jun 20 | 32 | 4 | 20 | 1 |
| 31 Mar 20 | 34 | 4 | 20 | 1 |
| 31 Dec 19 | 33 | 4 | 20 | 1 |
| 30 Sep 19 | 32 | 3 | 20 | 1 |
| 30 Jun 19 | 31 | 2 | 20 | 1 |
| 31 Mar 19 | 31 | 2 | 20 | 1 |
| 31 Dec 18 | 30 | 2 | 20 | 0 |
| 30 Sep 18 | 29 | 2 | 20 | 0 |
| 30 Jun 18 | 28 | 2 | 19 | 0 |
| 31 Mar 18 | 28 | 2 | 18 | 0 |
| 31 Dec 17 | 27 | 2 | 18 | 0 |
| 30 Sep 17 | 27 | 2 | 17 | 0 |
| 30 Jun 17 | 26 | 2 | 16 | 1 |
| 31 Mar 17 | 24 | 2 | 16 | 1 |
| 31 Dec 16 | 24 | 1 | 15 | 1 |
| 30 Sep 16 | 23 | 2 | 15 | 1 |
| 30 Jun 16 | 23 | 2 | 14 | 0 |
| 31 Mar 16 | 22 | 2 | 14 | 0 |
| 31 Dec 15 | 21 | 2 | 13 | 0 |
| 30 Sep 15 | 20 | 1 | 12 | 0 |
| 30 Jun 15 | 19 | 1 | 12 | 0 |
質の高い収益: ELMDは 高品質の収益 を持っています。
利益率の向上: ELMDの現在の純利益率 (14.1%)は、昨年(11.7%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: ELMDの収益は過去 5 年間で年間33.8%増加しました。
成長の加速: ELMDの過去 1 年間の収益成長率 ( 41.1% ) は、5 年間の平均 ( 年間33.8%を上回っています。
収益対業界: ELMDの過去 1 年間の収益成長率 ( 41.1% ) はMedical Equipment業界14.8%を上回りました。
株主資本利益率
高いROE: ELMDの 自己資本利益率 ( 20.6% ) は 高い とみなされます。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/22 15:07 |
| 終値 | 2026/05/22 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/06/30 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Electromed, Inc. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6
| アナリスト | 機関 |
|---|---|
| Kyle Bauser | B. Riley Securities, Inc. |
| Anderson Schock | B. Riley Securities, Inc. |
| Ilya Zubkov | Freedom Broker |